Is Your Home Making You Ill? What the Science Says About Mold and Respiratory Disease

There is a pattern that repeats itself — and that most doctors don't have time to investigate.

You have a persistent cough. Or rhinitis that doesn't respond properly to antihistamines. Or asthma that gets worse every winter, year after year, without any clear explanation. You run tests. You take the medication. The symptoms are managed but never go away. And no one asks: what is your home like?

Nobody asks when it was built. Whether there is damp on the walls. Whether you wake up congested every morning and the congestion clears within an hour of leaving the house. Whether your symptoms improve when you're on holiday and return in the first week back home.

These are simple questions. The link between housing affected by dampness and mold and chronic respiratory illness has been scientifically documented for decades. The World Health Organisation published specific guidelines on the subject in 2009. The European Environment Agency included residential dampness and mold as a significant causal factor in its 2024 report on chronic respiratory disease in Europe.

And yet, for most people living in this situation in Portugal — and there are many, as we will see — the home never enters the clinical conversation.

This article is an attempt to change that. Not to alarm. To inform.

What the numbers say about Portugal

Start with the structural facts, because they contextualise everything that follows.

According to Eurostat's EU-SILC household survey data, between 24 and 26 percent of the Portuguese population lives in housing affected by dampness or mold. That is the second highest figure in the European Union, exceeded only by Cyprus. The EU average is approximately 14 percent. Portugal has nearly double.

The 2021 INE Census data adds context: 82 percent of Portuguese buildings were constructed before the year 2000 — before any meaningful energy efficiency or insulation requirement. More than a third of buildings, 35.8 percent, need repair work. Not refurbishment. Basic repair.

Research published in 2023 in the scientific journal Pulmonology by Taborda-Barata and colleagues — a study specifically focused on Portugal — describes a "widespread lack of public awareness" of the link between indoor air quality and respiratory health. The authors conclude that Portuguese indoor air quality legislation "is not adequately adapted to Portuguese living conditions."

These three elements — high dampness prevalence, ageing housing stock, and lack of awareness — are not separate issues. They are the same problem seen from different angles.

What the WHO established

The WHO Guidelines for Indoor Air Quality: Dampness and Mould, published in 2009 and still the international reference, are careful in their language — as all good scientific reference literature should be. They distinguish between sufficient evidence, limited but suggestive evidence, and insufficient evidence.

For the following associations, the WHO considers there is sufficient evidence of a causal relationship:

Upper respiratory tract symptoms — rhinitis, congestion, sneezing, nasal irritation

Cough and wheeze in people without a prior asthma diagnosis

Exacerbation of asthma in people already diagnosed

Hypersensitivity pneumonitis in susceptible individuals

For the following, the WHO considers evidence limited but suggestive:

Lower respiratory tract illness in children

New-onset asthma — meaning damp housing as a potential causal factor in the development of asthma in people who didn't have it before

The distinction matters. "Sufficient evidence" means the causal relationship is established for purposes of public health policy and clinical guidance. "Limited but suggestive" means research points in that direction but hasn't yet reached the threshold of established causality.

The number that summarises the aggregate impact: the WHO estimates that 13 percent of childhood asthma cases in the WHO European Region are attributable to residential dampness. Not genetics. Not outdoor pollution. The housing where children sleep.

Thirteen percent. In Portugal, with dampness prevalence nearly double the European average, this figure may be higher.

How mold affects the body — the mechanisms

Beyond the statistics, understanding how mold produces respiratory effects is useful. There are three primary pathways.

Allergic pathway — IgE sensitisation

The immune system of certain people responds to fungal proteins — the allergens — by producing IgE antibodies. Once sensitised, the person reacts to subsequent exposures with typical allergy symptoms: rhinitis, conjunctivitis, wheeze, asthma exacerbation. The main clinically identified mold allergens include Alt a 1 from Alternaria alternata, Cla h 1 and Cla h 2 from Cladosporium, and multiple allergens from Aspergillus and Penicillium.

Sensitisation is cumulative — it can develop over months or years of exposure before symptoms become evident. This explains why many people develop mold allergies without associating the onset of symptoms with any specific change in their housing.

Non-allergic inflammatory pathway — beta-glucans and endotoxins

Beta-glucans are fungal cell wall components that activate the innate immune system — the inflammatory response that does not depend on prior sensitisation. Anyone exposed to sufficient concentrations of beta-glucans can develop airway inflammatory responses, regardless of whether they are allergic.

In water-damaged buildings, mold is rarely alone. Gram-negative bacteria thrive in the same damp conditions and release endotoxins — components of their cell membrane — that activate immune responses independent of mold. Recent research, including analyses published in 2025, suggests that the bacterial contribution to inflammation in damp buildings may equal or exceed that of mold itself. Research in this area is actively evolving.

Toxic pathway — mycotoxins and MVOCs

Certain mold species produce mycotoxins — chemical compounds with toxic effects on human cells. Stachybotrys chartarum produces satratoxins; Aspergillus fumigatus produces gliotoxin; various Aspergillus and Penicillium species produce ochratoxin A. These are not allergenic proteins — they are molecules that directly interfere with cellular processes.

MVOCs — microbial volatile organic compounds — are gaseous products of fungal metabolism. 1-octen-3-ol, geosmin, 3-methylfuran. They are responsible for the characteristic musty smell. Recent research shows that 1-octen-3-ol causes selective damage to dopaminergic neurons at relatively low concentrations, and that all 15 common MVOCs tested demonstrated genotoxicity in laboratory studies. This is a developing scientific area — the clinical implications for domestic exposure are still being quantified.

Groups with greater vulnerability

The risk is not equal for everyone. There are groups for whom residential mold exposure carries potentially more serious consequences.

Children

Children's lungs are developing. Their respiratory rate relative to body weight is higher than adults — they breathe more air per kilogram of body weight. They spend more hours at home, especially in their earliest years. The European Environment Agency estimates that children in damp housing have a 40 percent greater chance of developing asthma than children in dry housing. The most critical period of lung development — up to age 5 — is exactly the period of highest domestic exposure.

If your child has asthma, recurrent bronchitis, or repeated respiratory infections, the air quality of the home deserves investigation. Not as the only factor — but as a factor that is rarely considered and may be decisive.

Elderly people

With ageing, the mucociliary system — the natural airway clearance mechanism — becomes less efficient. Immune response is slower. Polypharmacy common in elderly individuals can interact with mycotoxin metabolism. In elderly populations with pre-existing chronic respiratory conditions — COPD, heart failure with pulmonary congestion — mold exposure can significantly worsen the condition.

Immunocompromised individuals

For people with a compromised immune system — through chemotherapy, organ transplant, HIV, or autoimmune conditions treated with immunosuppressants — the risk goes beyond allergy and inflammation. Aspergillus fumigatus is thermotolerant, grows at temperatures between 10 and 57 degrees, and produces spores of 2 to 3.5 micrometres that reach the pulmonary alveoli. In the immunocompromised, it can cause invasive aspergillosis — a systemic fungal infection with significant mortality. This is not a theoretical risk: it is one of the main fungal complications in oncology patients and transplant recipients.

Pregnant women

Research on mycotoxin exposure during pregnancy is still developing. Animal model studies show transfer of certain mycotoxins across the placental barrier. The clinical implications for inhalation exposure in humans are not yet fully established — but caution recommends minimising exposure during pregnancy, particularly in housing with visible mold or persistent musty smell.

The symptoms that go unrecognised

This section is the most important for anyone reading with suspicions about their own situation.

Chronic residential mold exposure rarely produces dramatic acute symptoms. Far more commonly, it produces a set of persistent low-intensity symptoms that are easy to attribute to other causes — stress, fatigue, "low immunity," the weather.

Signs that deserve attention, particularly if they coexist:

Symptoms that improve away from home and return when you come back. This is the single most important clinical indicator. If the nasal congestion you have every morning disappears within an hour at work, if the cough that accompanies you at home doesn't appear during holidays, if you consistently feel better away from your home — that is diagnostic information. It is not proof, but it is a signal that deserves investigation.

Rhinitis or chronic congestion that doesn't respond adequately to antihistamines. Allergic rhinitis to mold is mediated by IgE but also by non-IgE inflammatory mechanisms that conventional antihistamines don't fully block. A partial or temporary response to medication, with consistent relapse, may indicate continuous allergen exposure.

Recurrent or antibiotic-resistant sinusitis. Fungal sinusitis exists — Aspergillus and Bipolaris are documented causes of chronic sinusitis in immunocompetent individuals. More frequently still, recurrent bacterial sinusitis is facilitated by mucosal inflammation caused by continued exposure to fungal spores.

Wheeze or breathing difficulty that worsens at home, particularly at night or in the morning. Concentrations of spores and fungal fragments in enclosed environments are typically higher at night and in the early morning hours, when ventilation is minimal. Asthma symptoms with this temporal pattern, associated with damp housing, deserve investigation of the domestic environment.

Unexplained chronic fatigue, difficulty concentrating, or cognitive symptoms. This is a more recent and less established area of research. Systemic inflammation mediated by exposure to MVOCs and mycotoxins may have neurological effects — MMP-9 (matrix metalloproteinase-9), elevated in contexts of chronic inflammation associated with water-damaged buildings, is capable of degrading the blood-brain barrier. We are not claiming established causality for these symptoms in a domestic context — we are saying that the research exists, that it points in this direction, and that a conversation with a doctor makes sense if these symptoms coexist with the respiratory ones above.

A note on CIRS — what it is and what it isn't

In recent years, particularly in English-language online communities, information has circulated about Chronic Inflammatory Response Syndrome (CIRS), associated with the work of American physician Dr. Ritchie Shoemaker.

CIRS is described as a chronic multi-system syndrome caused by innate immune system dysregulation following prolonged exposure to water-damaged buildings. The diagnostic protocol includes specific blood markers — TGF-beta 1, C4a, VIP, MSH — and a genetic component based on HLA-DR haplotypes said to confer increased susceptibility.

It is important to be transparent about the scientific status of this question.

CIRS has a basis in research published in peer-reviewed scientific journals. Shoemaker's work includes studies with thousands of patients. In 2025, an updated analysis of the proposed causality mechanisms was published, suggesting that approximately 42 percent of the clinical presentation associated with water-damaged buildings may be attributable to Actinobacteria rather than specifically to mold. This is active research, not pseudoscience.

At the same time, CIRS as a diagnosis is not included in mainstream disease classification manuals (DSM, ICD), does not have consensus among pulmonologists and allergists outside the Shoemaker community, and the proprietary treatment protocol has not been subject to independent randomised clinical trials.

What this means practically: if you recognise in yourself a pattern of persistent multi-system symptoms with a likely relationship to water-damaged housing — respiratory symptoms, fatigue, cognitive issues, new food intolerances, symptoms that don't respond to conventional treatments — it is worth investigating the domestic environment and discussing the situation with a doctor. Not necessarily to seek a CIRS diagnosis. But because the link between damp housing and health is real, documented, and under-recognised.

The specific diagnosis belongs to a healthcare professional. Investigating the home environment can be a useful starting point.

What to do if you recognise yourself in this article

Don't panic. The presence of visible mold in a home is not automatically a health emergency. The risk depends on the species, the concentration, the duration of exposure, and individual susceptibility. Most people exposed to moderate levels of residential mold do not develop serious illness.

But if you recognise a pattern — persistent respiratory symptoms, consistent improvement away from home, known or suspected dampness — there are concrete steps to take.

First: document your symptom pattern. For two weeks, note when symptoms appear, when they improve, and in what context. Holidays away from home, work trips, weekends in another location. If there is a clear pattern of improvement away from home, that is valuable information to bring to your doctor.

Second: assess your home. Use the visual inspection guide available on this site. Identify visible mold, locate damp zones, measure relative humidity in the rooms you use most with a simple hygrometer.

Third: talk to your doctor — and mention your home. Bring the information you've documented. Ask whether your symptoms might have an environmental component. If your doctor is not familiar with this area — which is common, since medical training in domestic environmental medicine is limited — ask for a referral to allergy or pulmonology.

Fourth: if your situation warrants it, consider a professional home assessment. An independent inspection with a moisture meter and thermal imaging camera can identify the extent and origin of the problem. If needed, laboratory air or surface analysis can identify the species present and the concentrations. This information can be relevant both to your health and to resolving the housing problem.

The link between where we live and how we feel is not a new idea. Hippocrates wrote about it two and a half thousand years ago. Modern science has given it precision and mechanisms. What is missing, in Portugal and across much of Europe, is for this link to be recognised in daily life — by the doctors treating the symptoms, by the landlords managing the properties, and by the people living in them.

Your health and your home are not separate subjects. In many cases, they are the same subject.